CDCA8 and metastatic neoplasm: Among the nominated hub genes, CDCA8 and TROAP consistently emerged as markers of aggressive disease biology, demonstrating associations with subsequent metastasis in initially non-metastatic patients and with adverse survival among patients presenting with metastatic disease.